You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 93 No. 1, January 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (74)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Scleromyxedema

A Variant of Lichen Myxedematosus

EARL J. RUDNER, MD; AMIR MEHREGAN, MD; HERMANN PINKUS, MD

Arch Dermatol. 1966;93(1):3-12.


Abstract

Two patients with typical skin lesions of scleromyxedema (lichen myxedematosus) are described. The disorder is characterized by proliferation of fibroblasts and excessive deposition of acid mucopolysaccharides in the dermis. Quantitative elevated levels of acid mucopolysaccharides were demonstrated in the serum and skin of one patient. Each patient presented a clinical course ending in fatality, consisting of coronary atherosclerosis and bizarre central nervous system symptoms. Acid mucopolysaccharides were not demonstrated by histochemical examination of other organs at autopsy. A review of other similar cases indicates that abnormalities of serum proteins, bone marrow, and other systemic symptoms may rarely accompany this condition. It is postulated that scleromyxedema may be a disorder of altered fibroblastmucopolysaccharide balance and represent a special group under the lichen myxedematous conditions.



Author Affiliations

DETROIT

From the Department of Dermatology, Wayne State University College of Medicine, and Detroit Receiving Hospital, Detroit.


Footnotes

Accepted for publication Aug 23, 1965.

Reprint requests to 1400 Chrysler Expwy, Detroit, Mich 48207 (Dr. Rudner).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Scleroderma-like acute renal crisis in a patient with scleromyxedema
Gwinner et al.
Nephrol Dial Transplant 2007;22:2063-2067.
FULL TEXT  

Thalidomide as a Potential Treatment for Scleromyxedema
Caradonna and Jacobe
Arch Dermatol 2004;140:277-280.
FULL TEXT  

Plasmapheresis in a Patient With Scleromyxedema
Westheim and Lookingbill
Arch Dermatol 1987;123:786-789.
ABSTRACT  

Papular Mucinosis: A Clinicopathologic Study of Four Patients
Farmer et al.
Arch Dermatol 1982;118:9-13.
ABSTRACT  

Treatment of Scleromyxedema With Melphalan
Harris et al.
Arch Dermatol 1979;115:295-299.
ABSTRACT  

Scleromyxedema
Wright et al.
Arch Dermatol 1976;112:63-66.
ABSTRACT  

Lichen Myxedematosus: A Dermal Infiltrative Disorder Responsive to Cyclophosphamide Therapy
Howsden et al.
Arch Dermatol 1975;111:1325-1330.
ABSTRACT  

Scleromyxedema: A Dramatic Response to Melphalan
Feldman et al.
Arch Dermatol 1969;99:51-56.
ABSTRACT  

Pachydermoperiostosis: Touraine-Solente-Gole Syndrome
HAMBRICK and CARTER
Arch Dermatol 1966;94:594-608.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.